The dermatologist and the HIV/AIDS pandemic

Area of Science:

• Clinical Medicine
• Immunology
• Dermatology

Background:

• The clinical progression of Human Immunodeficiency Virus (HIV) disease has undergone significant transformation over the past three decades.
• Basic biomedical research has elucidated critical aspects of HIV pathogenesis, contributing to improved disease understanding.
• The development of potent antiretroviral therapies has revolutionized HIV treatment by interrupting viral replication and mitigating immune system damage.

Purpose of the Study:

• To highlight the evolving role of dermatologists in the comprehensive management of HIV-1 disease.
• To underscore the importance of dermatological expertise in recognizing early signs of HIV and managing treatment-related complications.

Main Methods:

• Review of clinical observations and research findings related to HIV disease progression.
• Analysis of the impact of antiretroviral therapies on HIV clinical course.
• Examination of the role of dermatologists in HIV patient care.

Main Results:

• Dermatologists were instrumental in the initial identification of HIV disease in the early 1980s.
• Skin and mucous membrane conditions serve as important indicators of HIV-1 disease.
• Antiretroviral drug therapies have dramatically altered the natural history of HIV infection.

Conclusions:

• Dermatologists continue to be vital in identifying HIV-1 associated mucocutaneous conditions.
• Effective management of antiretroviral therapy side effects by dermatologists improves patient outcomes.
• Dermatologists contribute to HIV prevention efforts through the control of other sexually transmitted infections.